2013

December 

•  "Is it necessary to understand the MoA?"
• Christopher A Bravery, PhD
• Speaker, chair intro
• Informa’s 4th Annual Cell Therapy Manufacturing
• Brussels, Belgium.

October 

• "Potency Assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry"
• Dr. Christopher Bravery, PhD
• Speaker, moderator
• IBC’s 3^rd Annual Cell Therapy Bioprocessing Conference
• Bethesda, USA.

June

• "Understanding Mechanisms of Action and Identifying Relevant Biological Activities: Why are they so important?" 
• Dr. Christopher Bravery, PhD
• Speaker
• PDA Europe, Advanced Therapy Medicinal Products Conference
• Florence, Italy.

• "Navigating the Uncertainties of Product Quality"
• Dr. Christopher Bravery, PhD
• Speaker
• IChemE, Biomedical Engineering Special Interest Group: Product Development in Regenerative Medicine.
• London UK.

April

• "19th Annual ISCT Meeting"
• Dr. Christopher Bravery, PhD
• Preconference GRP chair, session chair.
• Skycity Auckland Convention Center
• Auckland, New Zealand

January

• Workshop moderator and "Potency ISCT-PPD" 
• Dr. Christopher Bravery, PhD
• Workshop, speaker
• "Phacilitate. Cell & Gene therapy forum 2013".
• Grand Hyatt, Washington, DC.